Date post: | 20-Jan-2017 |
Category: |
Health & Medicine |
Upload: | naveen-kumar |
View: | 246 times |
Download: | 0 times |
MANAGEMENT OF DIABETESIN THE ICU
DR A P Naveen KumarChief Specialist ( Gen. Med. )
Visakha Steel General Hospital
Reasons for Deteriorated Glucose Control During Hospital Admissions
Hyperglycemia
“Stress hyperglycemia” Corticosteroid Therapy Hyperalimentation solutions Medication/insulin omission Insulin errors
Netchick LN, Am J Med 113:317, 2003
Counterregulatory hormones• Cortisol• Catecholamines• Glucagon• Growth Hormone
Glucose utilization
Glucose production
Glucose FFAs
LipolysisFFAs
(-)
(-)
Stress HyperglycemiaStress Hyperglycemia
Metchick LN et al, Am J Med 113:317, 2003Kitabchi AE, Diabetes Care 24:131, 2001
(-)
The Increasing Rate of Diabetes Among Hospitalized Patients
Hospitalizations for Diabetes as a Listed Diagnosis
0
1
2
3
4
5
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Hospital Discharges (millions)
48%
Available at: http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm. Accessed June 15, 2004.
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
Total In-patient Mortality
Normoglycemia Known New Diabetes Hyperglycemia
1.7% 3.0%
16.0% *
Mor
talit
y (%
)
* P < 0.01Umpierrez GE et al, J Clin Endocrinol Metabol 87:978, 2002
0
10
20
30
Hyperglycemia and Pneumonia Outcomes
BG (mg/dl) < 110 110 - <198 198 - <250 ≥250
* *
* *
* p: < 0.05 vs BG < 198 mg/dl (11 mmol/L)
Admission glucose (mg/dl)
%
McAllister et al, Diabetes Care 28:810-815, 2005
N= 2,471 patients with CAP
0
5
10
15
20
25
30
Mortality
HospitalComplications
Hyperglycemia*: A Common Comorbidity in Medical-Surgical Patients in a Community Hospital
62%62%
12%12%
26%26%
NormoglycemiaKnown DiabetesKnown DiabetesNew Hyperglycemia
Umpierrez G et al, J Clin Endocrinol Metabol 87:978, 2002
n = 2,020
* Hyperglycemia: Fasting BG 126 mg/dl or Random BG 200 mg/dl X 2
Hyperglycemia in Hospitalized Patients• Hyperglycemia (>200 mg/dL x 2) occurred in 38% of
hospitalized patients
– 26% had known history of diabetes
– 12% had no history of diabetes
• Newly discovered hyperglycemia was associated with:– Longer hospital stays– higher admission rates to intensive care units– Less chance to be discharged to home (required more
transitional or nursing home care)
Umpierrez GE, et al. J Clin Endocrinol Metab. 2002;87:978–982.
Hyperglycemia in Hospitalized PatientsHyperglycemia in Hospitalized Patients
– Surgery– Catheters– Intravenous Access
Problems with wound healing
Problems with tissue and organ perfusion
High-risk for bacterial infection
02468
10121416
<150 150-175 175-200 200-225 225-50 >250
Average Post-operative glucose (mg/dl)
Mor
talit
y
Cardiac-related mortalityNoncardiac-related mortality
Mortality of DM Patients Undergoing CABG
Furnary et al J Thorac Cardiovasc Surg 2003;123:1007-21
How do we know that hyperglycemia is bad?
• Hyperglycemia associated with morbidity and mortality in various epidemiologic studiesMyocardial infarctionStrokeTraumaSurgeryMedical ICUBurnsPediatric ICU
IS IT DIFFERENT FROM OUTPATIENT MANAGEMENT
Acute illness results in number of physiological changes
increase in circulating stress hormones
sepsis and infection and hypotension and shock
therapeutic usage of glucocorticoids
Nutritional and clinical instability
Diagnosis of diabetes and hyperglycemia in hospital setting
• Patients with known history of diabetes can be admitted in hospital
• Hyperglycemia detected in the hospital it could be newly detected diabetes it could be stress hyperglycemia
• Above two can be differentiated by the measurement of HBA1C
Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation (NICE-SUGAR)
• Nice sugar study the largest trial to date intensive insulin therapy is associated with increased hypoglycemia and increased mortality
• Therefore it is recommended to maintain blood glucose level between 140 - 180 mgs
• A lower blood glucose target (not less than 100mgs) may be appropriate in selected patients
NICE-SUGAR Study Outcomes
Outcome Measure
Intensive Group
Conventional Group
Morning BG (mg/dL) 118 + 25 145 + 26
Hypoglycemia(≤ 40mg/dL)
206/3016 (6.8%)
15/3014(0.5%)
28 Day Mortality (p=0.17) 22.3% 20.8%
90 Day Mortality (p=0.02) 27.5% 24.9%
The NICE-SUGAR Study Investigators. N Engl J Med. 360:1283-1297, 2009.
Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial
• People with diabetes who suffer an acute myocardial infarction (MI) are at markedly increased risk of future cardiovascular morbidity and mortality.
• The DIGAMI study compared "conventional" anti-diabetic therapy to intensive insulin therapy consisting of acute insulin infusion during the early hours of MI and thrice-daily subcutaneous insulin injection for the remainder of the hospital stay and a minimum of 3 months thereafter.
• 1-year mortality was statistically significant.
Glycemic Threshold in Acute MI and Intervention (PTCA)
DIGAMI supports BG < 180 mg/dlMinimal other data: - PTCA reflow better with BG 159 than
209 mg/dl
Iwakura K: JACC 2003; 41:1-7
Malmberg BMJ 1997;314:1512Malmberg BMJ 1997;314:1512
AACE-ADA Consensus Statement onInpatient Glycaemic Targets
Recommends using insulin therapy if blood glucose levels exceed 180 mg/dL
Moghissi E, et al. Diabetes Care 2009; 32 (6):1119-1131
Moghissi et al. Endocr Pract 2009;15:353–69
Inpatient glycaemic targets
• Insulin infusion to control hyperglycaemia
• Starting threshold no higher than 180 mg/dL
• Maintain BG between 140 and 180 mg/dL– Possible greater benefit at lower end of range
• Somewhat lower targets may be appropriate in selected patients
• Targets <110 mg/dL are not recommended
Recommended140–180 mg/dL
May be appropriate110–140 mg/dL
Not recommended<110 mg/dL
Not recommended>180 mg/dL
Insulin
The most powerful agent we haveto control glucose
only
IV Insulin Protocol
In all NMH Surgical ICU’s glucose levels are checked every hour upon admission. If glucose is greater then 110mg/dL X 2 or >200mgdL X 1, insulin drip is started.
Hyperglycemia is treated in all patients, even in the absence of a diabetes diagnosis.
Suggested protocol for insulin infusion in icu
A preparation 50 units of regular insulin dissolved in 50 ml normal saline in a 50 ml disposable syringes
B. Mode of administration
IV infusion with an electronic syringe pump/infusion pumps
C. Primary target
To maintain blood sugar level with a predefined target 140 mg/dl
D. Control methodology
Blood sugar to be controlled gradually in case of severe hyperglycemia by titrating the dose of IV insulin
Suggested protocol for insulin infusion in icu continued
E. Pre-requisites Initially 15–20mL of solution should be flushed through plastic tubing to saturate the insulin binding sites in the tubing
F. Targets Dose should be adjusted as per the levels of blood sugar
G. Monitoring Either by capillary blood glucose or from the venous site/central line
Portland Protocol• Start insulin infusion as follows:
http://www.hospitalmedicine.org/AM/Template.cfm?Section=Home&Template=/CM/ContentDisplay.cfm&ContentID=11490 . Accessed on 11/11/2011
24
Blood Glucose (mg/dL)
Intravenous Insulin Bolus
(IU)
Initial Insulin Rate (IU/hour)
Type 2 DM Type 1 DM
80–120 0 0.5 1121–180 0 1 2181–240 4 2 3.5
241–300 8 3.5 5
301–360 12 5 6.5> 360 16 6.5 8
Portland Protocol (contd…)• Insulin titration:
Furnary AP et al, Ann Thorac Surg 1999;67:352-62 25
BG (mg/dL) Instructions
>250 If > 10% lower than prior BG, no changeIf < 10% lower or higher BG, ↓ by 1 IU/hr
201-250 If lower BG, no changeIf higher, ↓ by 0.5 IU/hr
151-200 No change in drip rate
101-150 If < 10% lower BG, ↓ by 0.5 IU/hrIf > 10% lower BG, ↓ rate by 50%
< 100Hold insulin (25 ml of 50% dextrose if BG < 75). When BG >150 mg/dl, restart at 50% of previous rate
Yale Insulin Infusion Protocol• Insulin infusion:
– Mix 1 U regular human insulin per 1 mL 0.9% NaCl. Administer via infusion pump in increments of 0.5 U/h
• Bolus and initial infusion rate:
– Divide initial BG by 100, round to nearest 0.5 U for bolus and initial infusion rates
• Example: Initial BG = 325 mg/dL: 325/100 = 3.25, round up to 3.5, IV bolus = 3.5 U + start infusion at 3.5 U/h
• Subsequent rate adjustments:
– Changes in infusion rate are determined by the current infusion rate and the hourly rate of change from the prior BG level
Goldberg PA, et al. Diabetes Care. 2004;27:461-467. 26
Titration of insulin dose according to blood glucose level
Blood glucose levels(mg/dl) Dosage of insulin infusion
<100 No insulin to be given
100-149 1-1.5 units/hour
150-199 2 units/hour
200-249 2.5 units/hour
250-299 3 units/hour
300-349 3.5 units/hour
350-399 4 units/hour
Algorithm 1: Start with most patientsAlgorithm 2: Patients with post coronary bypass surgery, or solid organ transplantation, or receiving glucocorticoid therapy, or diabetes receiving more than 80 units of insulin/day
Patient Age Weight Kg
Blood glucose Initial Insulin Infusion rate Units/hour
Level (mg/dl)
Algorithm 1 Algorithm 2 Other
Less than 6061-109
Call AnesthesiologistHold insulin infusion, check glucose in 1 hourAnd follow the schedule
110-119 0.5 1_________
120-149 1 1.5________
150-179 1.5 2________
180-209 2 3_________
210-239 2 4_________
240-269 3 5_________
270-299 3 6_________
300-329 4 7_________
330-359 4 8_________
360-399 6 10________
400 or Greater 8 12________
65 yo Male without a previous hx of DM, s/p CABG x3 and MVRNPO, BS= 162. BG q 1 hour
Using the Insulin DripUsing the Insulin Drip
Titration of Insulin Drip
One hour later, BG=230. Previous BG 162One hour later, BG=230. Previous BG 162 An increase of 68An increase of 68
Give a Bolus of Give a Bolus of 3 3 unit(s) unit(s)
Increase Drip Rate by Increase Drip Rate by 1 1 unit(s) to unit(s) to 3 3 unit(s) unit(s)
KRINSLEY PROTOCOL
Diet Monitoring
NPO Q6 hours. 6AM, Noon, 6PM, Midnight
PO Diet 1 Hour Before Meals, QHS
Tube Feedings Q6 hours. 6AM, Noon, 6PM, Midnight
Glucose Value Action (SubQ insulin)
<140 No Treatment
140-169 3 units Regular Insulin
170-199 4 units Regular insulin; Recheck glucose value in 3 hours
200-249 6 units Regular insulin; Recheck glucose value in 3 hours
250-299 8 units Regular insulin; Recheck glucose value in 3 hours
300+ 10 units Regular insulin; Recheck glucose value in 3 hours
Basal Insulin
32
Nutritional Insulin
• Given as rapid-acting analogue or regular insulin, for those patients who are eating meals
• Must be matched to the patient’s nutrition
• Should not be given to patients who are not receiving nutrition (e.g., NPO)
• Can be estimated to be about ½ of the total daily dose of insulin
33
Correctional Insulin
• Extra insulin given to correct hyperglycaemia, in addition to basal and nutritional insulin
• Rapid-acting or regular insulin is generally used
• Customized to the patient using an estimate of the patient’s insulin sensitivity
• If correctional insulin is required consistently, or in high doses, basal and/or nutritional insulin doses need to be modified
34
Physiologic Subcutaneous Insulin Guidelines
Step Action Comments
1
• Measure blood glucose before meals and at bedtime, or every six hours if nothing by mouth
• Stop oral agents
• Order A1C if none obtained in past 30 days
Initiate protocol for:
•Patients with known DM
•Anyone with:• ≥ 2 random BG readings
> 180 mg/dL or• Fasting glucose > 126
mg/dL
Nau KC, et al. Am Fam Physician. 2010 May 1;81(9):1130-1135 35
Physiologic Subcutaneous Insulin Guidelines (contd…)
Step Action Comments
2Calculate initial total daily dose of insulin
• 0.3 IU/kg: underweight; older age; hemodialysis
• 0.4 IU/kg: normal weight
• 0.5 IU/kg: overweight
• ≥ 0.6 IU/kg: obese; glucocorticoids; insulin resistance
Nau KC, et al. Am Fam Physician. 2010 May 1;81(9):1130-1135 36
Physiologic Subcutaneous Insulin Guidelines (contd…)
Step Action Comments
3 50 % of the total daily dose as long-acting basal insulin
Insulin glargine or NPH insulin used
4
50 % of the total daily dose as short-acting nutritional insulin given in three divided doses zero to 15 minutes before meals (if eating) or before bolus tube feeds
If continuous tube or parenteral feeds, consider every six hour dosing of short-acting or regular insulin; hold if nothing by mouth
Nau KC, et al. Am Fam Physician. 2010 May 1;81(9):1130-1135 37
Physiologic Subcutaneous Insulin Guidelines (contd…)
Step Action Comments
5Select a scale of short-acting correctional insulin given zero to 15 minutes before meals
Use patient's insulin sensitivity as a guide for initial scale selection
6
Subsequent daily adjustment of total daily dose based on previous day's total units given
--
Nau KC, et al. Am Fam Physician. 2010 May 1;81(9):1130-113538
Correctional Insulin Dosing
Blood glucose level (mg/dL)
Insulin-sensitive dosing
(units of insulin)*
Standard dosing (units of
insulin)†
Insulin-resistant dosing
(units of insulin)‡
150 to 199 1 1 2200 to 249 2 3 4250 to 299 3 5 7300 to 349 4 7 10
> 349 5 + call 8 + call 12 + call
Nau KC, et al. Am Fam Physician. 2010 May 1;81(9):1130-113539
*— Total daily dose: less than 40 units.†— Total daily dose: 40 to 80 units.‡— Total daily dose: greater than 80 units.
CASE SCENARIO
• A 60 kg. male on OHA
• What are you going to do
• Basal insulin - 12 units
• Nutritional insulin - 4 units
40
CASE SCENARIO
• Overweight female aged 65 using human mixtard morning 32 and evening 24 units
• Basal insulin - 26 units
• Nutritional insulin - 10 units
• Correctional insulin - standard dosing
41
Case scenario56 year old woman with DM2 admitted with a diabetes-related foot infection which may require surgical debridement in the near future, eating regular meals.
- Weight: 100 kg- Home medical regimen: Glipizide 10 mg po qd, Metformin
1000 mg po bid, and 20 units of NPH q HS- Control: A recent HbA1c is 10%, POC glucose in ED 240 mg/dL
What are your initial orders for basal and nutritional insulin?How would you manage the oral agents?
Case scenario
• Discontinue oral agents
• Total daily dose 100 kg x 0.6 units/kg/day = 60
• Basal: Glargine 30 units q HS
• Nutritional: Rapid-acting analogue 10 units q ac at the first bite of each meal
• Correction: Rapid-acting analogue per scale q ac and HS (Note: Use correctional insulin with caution at HS, reduce the daytime correction by up to 50% to avoid nocturnal hypoglycemia)
Case scenario
The patient is made NPO after midnight for a test, but is expected to be able to resume her diet at lunch or dinner the next day. What changes would you make to her management program regarding glucose monitoring and her insulin program? Would you provide dextrose in her IV fluids?
Case scenario
• Change bedside glucose checks to q 6 hours, as the patient will not be eating meals
• Continue basal insulin: If using glargine, continue as is. If using NPH, continue in equal twice daily doses with a dose reduction of 1/3-1/2 while NPO.
• Hold nutritional insulin while NPO
• Provide a low level of intravenous dextrose (e.g. 75-125 cc/hr of a D5 containing solution)
• Continue appropriate correctional insulin for hyperglycemia
Case scenario
56 year old woman with type 1 diabetes admitted with a diabetes-related foot infection. The wound is an infected ulcer on the fifth digit with necrosis. The plan is for amputation first thing in the morning, so the patient will be NPO after midnight. However, she is expected to resume a regular diet at lunch the following day after surgery.
- Weight: 70 kg - Home medical regimen: 70/30 insulin 14 units BID- Control: A recent HbA1c is 9%, POC glucose in ED is 240 mg/dL
It is now dinner time, and the patient took her last dose of insulin before breakfast. What insulin would you give her now (before dinner) and how would you modify her regimen given the plan for NPO after midnight?
Case scenario
• TDD by weight = 70 kg x 0.4 units/kg/day = 28 units
• Her home TDD is 28, but patient has very poor control on this regimen, so increase (arbitrarily) by 20% = 34 units
• IV dextrose infusion while NPO (e.g. D5 at 75-150 cc/hr)
• Basal: Glargine 17 units q HS
• Nutritional: Rapid-acting insulin 6 units q ac at the first bite of each meal
• Correction: Rapid-acting insulin per scale q ac and HS
Post Operative Management: Goals
• In patients who are eating– Use regular/ rapid acting insulin before meals– 1 U insulin S.C for every 10-15 gm of
carbohydrate or by “Miami 4/12 rule”
Meneghini L, Perioperative management of diabetes: Translating evidence into
practice. Cleve Clin J Med. 2009 Nov; 76 Suppl 4:S53-9
48
Basal replacementWeight (kg) / 4
Prandial coverageWeight (kg) / 12
Example: 60 kg patientBasal: 60/4 = 15 U daily
Example: 60 kg patientPrandial: 60/12 = 5 U
before each meal
“Miami 4/12 rule”
Treatment of Hypoglycaemia in Hospitalized Patients
• Any BG <80 mg/dl:– Administer IV 50% dextrose = (100-BG) x 0.4 ml
• If eating, may use 15 g of rapidly absorbed carbohydrate (prefer glucose tablets)
• Do not hold insulin when BG is normal
Advice at Hospital Discharge
Umpierrez GE. Cleveland Clinic Journal Of Medicine 2011; 78 (6):379-384
strategies for preventing Hypoglycemia
• Less aggressive blood glucose targets (AACE/ADA guidelines blood sugar between 140-180mgs)
• Improved glucose monitoring• If Blood glucose level <100mgs reassess the
insulin protocol• If blood sugar <70mgs modify therapy • We should be very careful patients with altered
nutritional state heart failure renal or liver disease .malignancy, sepsis
• While reducing corticosteroid dose
Recommendations:Recommendations:Diabetes Care in the Hospital Diabetes Care in the Hospital
Goals for blood glucose levelsCritically ill patients• Initiate insulin therapy for persistent hyperglycemia starting no
greater than 180 mg/dL (10 mmol/L); once started, glucose range of 140–180 mg/dL (7.8–10 mmol/L) is recommended A
• More stringent goals, 110–140 mg/dL (6.1–7.8 mmol/L) may be appropriate for selected patients if achievable without significant hypoglycemia C
• Critically ill patients require an IV insulin protocol with demonstrated efficacy, safety in achieving desired glucose range without increasing risk for severe hypoglycemia E
ADA. 13. Diabetes Care in the Hospital, Nursing Home, and Skilled Nursing Facility. Diabetes Care 2015;38(suppl 1):S80
Recommendations:Recommendations:Diabetes Care in the Hospital Diabetes Care in the Hospital
Goals for blood glucose levelsNon-Critically ill patients• If treated with insulin, generally premeal blood glucose targets of
<140 mg/dL (7.8 mmol/L) with random blood glucose <180 mg/dL (10.0 mmol/L) are reasonable, provided these targets can be safely achieved. C– More stringent targets may be appropriate in stable patients with previous tight
glycemic control. – Less stringent targets may be appropriate in those with severe
• A basal plus correction insulin regimen is the preferred treatment for patients with poor oral intake or who are taking nothing by mouth (NPO). An insulin regimen with basal, nutritional, and correction components is the preferred treatment for patients with good nutritional intake. A
ADA. 13. Diabetes Care in the Hospital, Nursing Home, and Skilled Nursing Facility. Diabetes Care 2015;38(suppl 1):S80
THANK YOU